Ledger.Open graph →
SEC Form D · filed January 29, 2021

Vita Therapeutics, Inc

Offering
$20.0M
Sold
$20.0M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
BALTIMORE, MD
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Douglas Falk · Baltimore, MDExec · DirectorVlad Coric · Baltimore, MDDirectorPat Lavecchia · Baltimore, MDDirectorStephen Taylor · Toronto, Ontario, CanadaDirectorPaul G. Smith · Toronto, Ontario, CanadaExec · DirectorJohn Eckert · Toronto, Ontario, CanadaDirectorDaniel Herz · Philadelphia, PAExec · DirectorAlan Marshall · St. George's, BermudaDirectorAnthony R. Puckett · Tempe, AZDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗